Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Paul Ausick | Apr 18, 2017 at 7:50 AM EDT

How Dumping ACA Exchanges Boosted UnitedHealth’s Profits

Exiting the ACA individual exchanges boosted UnitedHealth's profit while nipping its revenues and subscriber numbers. The company also raised its…

Paul Ausick | Apr 17, 2017 at 12:10 PM EDT

Why HCA Holdings Stock Tumbled Monday

Hospital services provider HCA announced disappointing preliminary financial results for the first quarter of 2017. Shares tumbled more than 3%…

Jon C. Ogg | Apr 17, 2017 at 10:20 AM EDT

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

When drugs are expected to get FDA approval and show positive data but don't, the underlying stocks of drug and…

Lee Jackson | Apr 17, 2017 at 10:00 AM EDT

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

With interest rates once again dropping as the geopolitical worries ratchet up, investors are concerned about owning good stocks and…

Chris Lange | Apr 13, 2017 at 11:30 AM EDT

Sorrento Therapeutics Gears Up for Secondary Offering

Sorrento Therapeutics saw its shares plunge on Thursday after the company announced a secondary offering.

Chris Lange | Apr 12, 2017 at 10:40 AM EDT

Neurocrine Biosciences Wins Big With FDA Approval

Neurocrine Biosciences saw its shares jump after the company reported that the FDA had approved Ingrezza capsules for the treatment…

Chris Lange | Apr 12, 2017 at 9:10 AM EDT

Short Sellers Back Off Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased in most of…

Chris Lange | Apr 12, 2017 at 8:25 AM EDT

Short Sellers Run for Cover From Major Pharma Stocks

The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of…

Jon C. Ogg | Apr 11, 2017 at 10:45 AM EDT

Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly

Several analysts and market pundits have been positive toward Eli Lilly lately, including now a price target raise at JPMorgan.

Chris Lange | Apr 11, 2017 at 10:25 AM EDT

Why Jefferies Still Sees Exponential Upside in TherapeuticsMD

A letter from the FDA citing deficiencies in its treatment for moderate to severe dysparaeunia due to vulvar vaginal atrophy…

Chris Lange | Apr 10, 2017 at 10:35 AM EDT

Cytori Rises on Crucial FDA Approval

Cytori Therapeutics saw its shares explode after it was reported that the firm received approval from the FDA for its…

Chris Lange | Apr 10, 2017 at 10:15 AM EDT

OncoMed Hits All-Time Low After Failed Trial and Licensing Fallout

OncoMed Pharmaceuticals saw its shares crumble after the company announced that Bayer Pharma is terminating its option agreement with the…

Lee Jackson | Apr 10, 2017 at 9:50 AM EDT

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

A massive new Jefferies research report reminds investors that as a rule the first quarter is traditionally slower for biotechnology…

Chris Lange | Apr 10, 2017 at 9:00 AM EDT

Biohaven Files for IPO

Biohaven Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange | Apr 7, 2017 at 11:30 AM EDT

Catalyst Biosciences Sinks After Pricing Secondary Offering

Catalyst Biosciences watched its shares fall on Friday following the announcement of a secondary offering.

1 … 169 170 171 172 173 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

How Dumping ACA Exchanges Boosted UnitedHealth’s Profits

Why HCA Holdings Stock Tumbled Monday

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Sorrento Therapeutics Gears Up for Secondary Offering

Neurocrine Biosciences Wins Big With FDA Approval

Short Sellers Back Off Major Biotechs

Short Sellers Run for Cover From Major Pharma Stocks

Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly

Why Jefferies Still Sees Exponential Upside in TherapeuticsMD

Cytori Rises on Crucial FDA Approval

OncoMed Hits All-Time Low After Failed Trial and Licensing Fallout

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

Biohaven Files for IPO

Catalyst Biosciences Sinks After Pricing Secondary Offering

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

How Dumping ACA Exchanges Boosted UnitedHealth’s Profits

Why HCA Holdings Stock Tumbled Monday

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

Sorrento Therapeutics Gears Up for Secondary Offering

Neurocrine Biosciences Wins Big With FDA Approval

Short Sellers Back Off Major Biotechs

Short Sellers Run for Cover From Major Pharma Stocks

Analysts Keep Stacking Up Higher Targets and Expectations for Eli Lilly

Why Jefferies Still Sees Exponential Upside in TherapeuticsMD

Cytori Rises on Crucial FDA Approval

OncoMed Hits All-Time Low After Failed Trial and Licensing Fallout

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

Biohaven Files for IPO

Catalyst Biosciences Sinks After Pricing Secondary Offering

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income